Monday, April 11, 2022 9:49:03 AM
And price keeps going down. Trash
Recent NDRA News
- ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update • Business Wire • 05/18/2026 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/15/2026 08:14:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:01:19 PM
- ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accuracy and Reproducibility • Business Wire • 05/14/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/21/2026 12:00:21 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 09:10:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 08:29:26 PM
- ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update • Business Wire • 03/31/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 01:21:26 PM
- ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value • Business Wire • 03/25/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 02:48:01 AM
- ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care • Business Wire • 02/26/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2026 12:43:37 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2026 12:43:22 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2026 12:43:04 AM
- ENDRA’s TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use • Business Wire • 12/04/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2025 09:23:04 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 11/26/2025 01:30:32 PM
- ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker • Business Wire • 11/20/2025 01:00:00 PM
- ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results • Business Wire • 11/17/2025 01:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2025 09:38:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 09:27:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:24:12 PM
- ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA • Business Wire • 11/13/2025 01:00:00 PM
